On the surface of things, this press release from yesterday I find very interesting. No doubt for end-to-end workflows for digital pathology, much like glass slide pathology, pathologists will work in their LISs. These systems control order generation, accessioning, reporting, resulting and ultimately billing so services rendered can be remunerated. While synoptics for both oncology and non-oncology cases (e.g. medical liver and renal biopsies) are critical for structured reporting (and later data mining) which the mTuitive software is known for, it is not itself a complete LIS. Inspirata is clearly establishing itself as a scanner agnostic, application agnostic and LIS agnostic provider of integrated digital pathology systems for a complete solution rather than disparate applications. This will become increasingly important with the number of hospital mergers/acquisitions and disparate EMR and LIS platforms. Digital pathology adoption has been hamstrung by increasingly larger and larger integrated healthcare delivery systems without shared information platforms (i.e. lack of interoperability). Partnerships such as this to provide necessary information for case acquisition, case review and reporting will be required in the market place for digital pathology adoption on a broad scale. Perhaps time will tell as we see more instances of LIS integration with digital pathology systems and the necessary components for complete “theragnostic” and prognostic reporting integration with additional components such as tumor synoptics and molecular results integrated with slide (image) viewing and reporting as single solutions rather than separate applications.
Boston, MA – Structured data and synoptic reporting software company mTuitive, Inc., and cancer diagnostics and pathology workflow solution provider Inspirata, Inc., today announced a reseller and integration agreement that will embed mTuitive’s CAP eFRM™ software with Inspirata’s digital pathology cockpit. The integration will enable pathologists to record their diagnostic findings through Inspirata’s single-sign-on cockpit, which is part of the company’s end-to-end digital pathology workflow solution.
“This integration will make the diagnostic workflow significantly more efficient for pathologists,” says Inspirata Executive Vice President and Founder Mark Lloyd. “Our workflow solution and digital pathology cockpit already automate the process of assembling cases, viewing pre-annotated digital images of anatomic pathology slides and retrieving information from disparate diagnostic systems. Inserting mTuitive’s synoptic reporting software into the mix will enable pathologists to focus more of their time on the diagnostic process vs. trying to reconcile information across systems prior to completing their reports. And it offers the added value of creating discrete mineable data for cancer registries and databases.”
mTuitive’s CAP eFRM software enables pathology departments to capture and maintain structured diagnostic data and produce synoptic reports for anatomic pathology specimen findings. It is fully compliant with the College of American Pathologists’ (CAP) Cancer Protocols for Cancer Program Accreditation and Lab Accreditation Inspections.
“We believe our integration with Inspirata’s digital cockpit is a big plus…, not just for pathologists, but for the entire clinical team and, most importantly, patients who are waiting for their diagnosis,” says mTuitive CEO John Murphy. “Bundling CAP eFRM into Inspirata’s total solution-as-a-service will bring it to the desktops of more pathologists who are embracing the benefits of the digital era in pathology.”
About Inspirata, Inc.
Inspirata, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution as a service” delivery model. This comprehensive solution includes workflow automation and diagnostic tools to help pathologists work more efficiently. Inspirata’s solution also includes a suite of algorithms to extract relevant image-based information from digitized histology specimens for use as supplemental screening tools to assist pathologists with cancer detection and to aid in the prediction of disease progression and therapeutic responses. For more information, please visit www.inspirata.com or contact firstname.lastname@example.org
About mTuitive, Inc.
mTuitive, Inc. develops data capture and synoptic reporting software to assist health care professionals in recording clinical findings and maintaining compliance with established protocols and guidelines. mTuitive’s unique method of capturing structured information provides valuable data for pathology, surgery, oncology, and cancer staging applications. These products allow the clinical decision maker to conveniently receive alerts and reference materials directly at the point of care. mTuitive solutions improve care to the patient through quality assurance and error reduction while standardizing and automating manual reporting processes, reducing both time and labor costs. To learn more, visit www.mtuitive.com or follow mTuitive on Twitter at @mTuitive.
Category: Anatomic Pathology, Business, Clinical Laboratories, Clinical Pathology, Device Manufacturers, Digital Pathology News, File format, Informatics, Laboratory Coding & Billing, Laboratory Informatics, Laboratory Information Systems, Laboratory Management & Operations, Pathology News, Vendor products, Web/Tech, Whole slide